ClinChoice, founded in 1995, stands as a leading global full and functional service CRO (Contract Research Organization), marking its significant presence in the pharmaceutical, biotechnology, medical device, and consumer health industries. Headquartered in the United States, the company has notably expanded across the Americas, Europe, and Asia-Pacific, solidifying its role as a comprehensive global partner.
The company operates under the slogan "The Standard of Excellence", a testament to its distinguished product development and lifecycle management services. With three decades of industry experience, ClinChoice excels in regulatory expertise, clinical trial execution, and advanced pharmacovigilance and biometrics capabilities, reinforcing its trusted reputation.
Currently, ClinChoice has not disclosed recent investment rounds or investor information, suggesting potential opportunities for new investment engagements to capitalize on their global reach and industry expertise.